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ABSTRACT
Transformed astrocytes in the most aggressive form cause glioblastoma, the most common cancer in the central nervous system with high
mortality. The physiological electric field by neuronal local field potentials and tissue polarity may guide the infiltration of glioblastoma cells
through the electrotaxis process. However, microenvironments with multiplex gradients are difficult to create. In this work, we have
developed a hybrid microfluidic platform to study glioblastoma electrotaxis in controlled microenvironments with high throughput
quantitative analysis by machine learning-powered single cell tracking software. By equalizing the hydrostatic pressure difference between
inlets and outlets of the microchannel, uniform single cells can be seeded reliably inside the microdevice. The electrotaxis of two glioblastoma
models, T98G and U-251MG, requires an optimal laminin-containing extracellular matrix and exhibits opposite directional and electro-
alignment tendencies. Calcium signaling is a key contributor in glioblastoma pathophysiology but its role in glioblastoma electrotaxis is
still an open question. Anodal T98G electrotaxis and cathodal U-251MG electrotaxis require the presence of extracellular calcium cations.
U-251MG electrotaxis is dependent on the P/Q-type voltage-gated calcium channel (VGCC) and T98G is dependent on the R-type VGCC.
U-251MG electrotaxis and T98G electrotaxis are also mediated by A-type (rapidly inactivating) voltage-gated potassium channels and acid-
sensing sodium channels. The involvement of multiple ion channels suggests that the glioblastoma electrotaxis is complex and patient-
specific ion channel expression can be critical to develop personalized therapeutics to fight against cancer metastasis. The hybrid microfluidic
design and machine learning-powered single cell analysis provide a simple and flexible platform for quantitative investigation of complicated
biological systems.
VC 2020 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://
creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/5.0004893
I. INTRODUCTION
Glioma is one of the most common types of brain cancer and
the aggressive form of it, glioblastoma, contributes to poor progno-
sis, high mortality, and high probability of recurrence,1,2 due to the
infiltration nature of the disease. The highly infiltrative ability of
glioblastoma originates from the invasive/migratory ability of gli-
oma stem cells or brain tumor initiating cells.3,4 Not only glioma
cells are important, but also the microenvironment in the brain
helps shaping the heterogeneity of the glioma.5 The glioma cells
interact with the extracellular matrix (ECM), glial cells, and
immune cells in the brain and mediate the formation of peri-
vascular, peri-necrotic, and invasive tumor microenvironments.6–9
Understanding the molecular mechanisms of the invasiveness in
glioma cells with respect to the tumor microenvironment is vital
for developing new therapeutic options and improving the patient
outcome.10,11
In the brain, glial cells are immersed in an electric field created by
tissue polarity from brain macrostructures as well as the local field
potentials, which are established from the action potentials fired by the
neurons.12 A weak endogenous electric current has been shown to
serve as a guidance cue for neuroblast migration from the subventricu-
lar zone in mice,13 a region speculated as the origin of glioma tumori-
genesis.14 Thus, the physiological electric fields in the brain may play
an important role in mediating the glioma tumorigenesis and inva-
sion.15–19 Cells sense the electric field by bioelectrical activation of
voltage-sensitive proteins, mechanosensing due to electrokinetic phe-
nomena, or activated chemical signaling due to electrokinetically
polarized membrane receptors (Fig. S1). The voltage gradient creates a
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large voltage drop at the cellular membrane, which can directly
activate voltage sensitive proteins such as voltage-gated ion channels
that are most commonly expressed on excitable membranes at neu-
ronal synapses and neuro-muscular junctions.20 Among the voltage-
gated ion channels in the brain, calcium channels are especially
important as calcium influx plays a pivotal role in cellular signal-
ing.21,22 Calcium signaling is also important in glioma cell prolifera-
tion, resistance to therapy, and metastasis.23–27 Whether or not the
calcium signaling in glioma is mediated by electric field is still an
open question.
Conventional in vitro electrical stimulation systems for studying
cell responses in electrical microenvironments are bulky and the
experimental throughput is limited.28,29 To overcome these limita-
tions, a robust high-throughput in vitro platform that creates stable
electrical stimulation of cells and interfaces with automated micros-
copy is a prerequisite for rapid screening of targets and identifying
molecular mechanisms. To this end, we have developed a hybrid
poly(methylmethacrylate)/poly(dimethylsiloxane) (PMMA/PDMS)
microfluidic platform to reliably study glioblastoma single cell migra-
tion under multiplex dcEF stimulations that multiple antagonists can
be tested simultaneously to identify molecular mechanisms.
Quantitative single cell migration analysis is carried out by extracting
cell migration metrics such as the directedness, orientation, and speed
using robust machine learning-powered cell segmentation/tracking/
analysis software with stain-free phase contrast microscopy.30 Using
the hybrid microfluidic platform, the role of voltage-gated calcium
channels in calcium signaling pathways of glioblastoma electrotaxis is
investigated.
II. RESULTS
A. Multiplex electrotaxis experiments using a hybrid
multiple electric field chip (HMEFC)
To investigate cell electrotaxis and elucidate molecular mechanism
in different phenotypes, a reliable in vitromultiplex platform is required.
The hybrid multiple electric field chip (HMEFC) is designed by the
hybrid PMMA/PDMS approach17 [Fig. 1(a)]. Using PMMA-based
microfluidics, a versatile world-to-chip interface and 3D designs can be
easily integrated. Medium reservoirs (Component A) and interface for
electrical current introduction and medium withdraw (Component B)
can be easily fabricated using laser cutting and thermal bonding of
PMMA substrates [Fig. 1(b)]. In PDMS-based microfluidics, by using
double-layer microchannel design, the fluid and chemical transport in a
controlled microenvironment can be realized for studying cell electro-
taxis. An experiment with two chemical stimulations with four electric
field strengths of a ratio of 5.25:2.5:1:0 can be performed on a single
HMEFC, increasing the experimental throughput15,31,32 [Fig. 1(c)], see
more discussion in the supplementary material.
B. Uniform single cell seeding by submerged
manipulation in a hybrid multiple electric field chip
(HMEFC)
To analyze single cell migration in microchannels, cells must be
seeded sparsely and allowed to adhere and culture reliably.33,34
However, it is known that uneven distribution of cells due to fluid
flow, convection in suspension, and vessel movement after seeding can
cause aggregation and differentiation of cells.35 In particular, seeding
FIG. 1. The design of a hybrid multiple electric field chip (HMEFC). (a) the 3D rendered model of the final HMEFC. Double-layer microchannel design in the PDMS is shown;
(b) the schematic diagram of using the HMEFC for electrotaxis experiments. Complex 3D microfluidic structures and world-to-chip interface are established in PMMA compo-
nents A and B. Simplified chemical infusion can be performed using the medium reservoirs in the Component A. Electrical stimulation with salt bridge separation is integrated
in the Component B; (c) the channel design. The 10lm-tall first layer structures are shown in cyan. Multiple electric fields are created in Secs. I–IV and V–VIII with a strength
ratio of 5.25:2.5:1:0. Two chemical conditions can be introduced to Secs. I–IV and V–VIII from the two inlets with minimal cross-contamination.
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cells with minimum pressure difference in a microfluidic device for
reproducible single cell studies is challenging. In this work, we designed a
removable top reservoir on top of a microfluidic chip to balance the
hydrostatic pressure during cell seeding so human errors can be reduced.
Different cell loading methods affecting cell distribution in single
cell migration experiments are investigated, such as the tip loading
method, tip injection method, and a pressure-balanced submerged cell
seeding, as shown in Fig. 2.
FIG. 2. The results of U-251MG cell seeding inside microchannels by various methods. [Left column: (a), (d), (g), and (j)]. In the tip loading method, cells are introduced by
using gravitational flow with micropipette tips. The cells can flocculate inside the tips and in microchannels as illustrated in (d). The microscopy image of seeded cells is shown
in (g) and magnified in (j); [Middle column: (b), (e), (h), and (k)] in the tip injection method, cells are injected into the channels and tips are removed. The small hydrostatic pres-
sure differences between the inlet/outlet (shown as Dh) will contribute to hydrodynamic flow and disturb the cell distribution, causing non-uniform cell distribution and aggre-
gates as shown in (e). The microscopy image of seeded cells is shown in (h) and magnified in (k); [Right column: (c), (f), (i), and (l)] in our pressure-balanced submerged cell
seeding method, the hydrostatic pressure difference is eliminated. The injected cells remain uniform throughout the channel as shown in (f). The microscopy image of seeded
cells is shown in (i) and magnified in (l). The uniform and sparse cell seeding method is suitable for different applications such as single cell tracking, ensembled cell studies,
and cell assembly. The scale bars in [(g), (h), and (i)] represent 500lm. The scale bars in [(j), (k), and (l)] represent 200 lm.
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In the tip loading method [Fig. 2(a)], the cells flocculate in the
small pipet tip and cannot be dispersed uniformly in the microchannel
[Figs. 2(d), 2(g), and 2(j)]. In the tip injection method [Fig. 2(b)], the
cells are originally injected in the channels with uniform cell distribu-
tion. However, without balancing the microchannel inlet/outlet pres-
sure, the minute hydrostatic pressure difference between inlets and
outlets generates a small pressure-driven flow that displaces cells,
which lead to cell aggregates [Figs. 2(e), 2(h), and 2(k)]. Furthermore,
in the tip injection method, due to the small dimension of the punched
holes at inlet/outlet interfaces, bubbles are easily trapped and may be
introduced into microchannels, disrupting fluid advection and chemi-
cal transport.
By submerging inlets and outlets underwater using a reversibly
bonded top reservoir and balancing the pressure between inlets and
outlets [Figs. 2(c)], air bubbles can be avoided and pressure-driven
flow is prevented from affecting cell distribution. Moreover, using this
cell seeding method, only a minute amount of cells is needed (the vol-
ume of the microchannel). Uniformly distributed single cell seeding
across the entire microchannel is obtained for single cell migration
experiments [Figs. 2(f), 2(i), and 2(l)]. The top reservoir in our sub-
merged cell seeding setup can be easily removed after cells are seeded
and can be adapted to a wide range of microfluidic chips.
C. Glioblastoma electrotaxis requires an optimal
laminin-containing ECM
An effective ECM coating on the substrate is essential for cell adhe-
sion and formation of focal adhesions for cell migration.36,37
Glioblastoma can be molecularly classified into proneural, neural, classi-
cal, and mesenchymal types according to The Cancer Genome Atlas
(TCGA).38 We use two glioblastoma cell models, T98G, and U-251MG,
which are both of caucasian male origin and classified as mesenchymal
type with p53 mutant genotype.39,40 The adhesion and electrotaxis of
T98G and U-251MG glioblastoma cell lines on various ECMs are tested
in a double-layer hybrid multiple electric field chip (HMEFC) based on
the hybrid PMMA/PDMS design approach17 (Table S1). The migration
directedness, speed, and morphology of glioblastoma cells (see details in
Sec. IVE) are quantitatively analyzed by custom-made machine
learning-based single cell segmentation and tracking software from
stain-free phase contrast microscopy.30 The cell morphologies of the
two cell lines on various ECMs are shown in Fig. S2.
While standard poly(D-lysine) (PDL) and various combinations
of poly(L-ornithine) (PLO) and laminin have been used for glioblas-
toma electrotaxis,16,41 the adhesion and electrotaxis of T98G and
U-251MG are not always consistent and reproducible as shown in
Figs. S2 and S3. T98G and U-251MG electrotactic responses are also
not stably reproduced on collagen I, collagen IV, vitronectin, and
fibronectin coatings.
Both T98G and U-251MG cells adhere well and demonstrate
lamellipodia structures on substrates containing laminins, such as
pure laminin coating, or Geltrex.TM GeltrexTM is a growth factor-
reduced complex basement membrane extract purified from murine
Engelbreth–Holm–Swarm tumors containing laminin, collagen IV,
entactin, and heparin sulfate proteoglycan.42 Cells interact with lami-
nins through various integrins including a1b1, a2b1, a3b1, a6b1, and
a7b1.43,44 The integrins are believed to participate in the initiation of
electrotaxis through mechanosensitive pathways.45–47
The typical in vitro electric fields are in the range of 100–300
Vm1 among glioblastoma, neural stem cells, and other solid tumor
cell electrotaxis studies.16,48–51 Similar electric field strength has also
been used for therapeutic tumor treating pulsed electric field.18 Based
on this information, using our hybrid multiple electric field chip
(HMEFC), four electric field strengths (0, 57.1, 142.8, and 300V m1)
are created for simultaneous screening of cell behavior in four different
electric field strength (EFSs). Note that our selected EFS strength is
greater than the physiological electric field measured along the rostral
migratory stream in the mice brain (around 3V m1), though the
electric field in human brains may be larger.13
Discussed in detail in Sec. IVD, under electrical stimulation, the
electrotaxis of both T98G and U-251MG is more prominent and
reproducible on GeltrexTM coatings; hence, all the studies in the fol-
lowing sections are based on GeltrexTM coatings. The detailed data of
T98G and U-251MG electrotaxis on various ECMs are shown in
Table S2 of the supplementary information.
An interesting observation is found in U-251MG cells on
iMatrix-511-coated substrates. U-251MG cells demonstrate large
lamellipodia associated with high migratory speed (15.45lm h1
under 300V m1, P< 0.0001) but with diminished directedness (0.01,
P< 0.0001). Note that iMatrix-511 is a recombinant truncated laminin
with a5b1c1 subunits and interacts with cells through the a6b1 integ-
rin.52,53 This suggests that the specific molecular configuration of lami-
nins in ECMmay be vital for electrotaxis.
While it is understood that ECMs in the tumor microenviron-
ment are important,54 glioblastoma cells demonstrate preference for
adherence and electrotaxis on laminin-coated surfaces. Within the
brain microenvironment, laminin expressions are restricted to the
basement membrane of neural vasculature55 and a perivascular tumor
microenvironment is especially vital for glioblastoma metastasis.10,56
Therefore, the correlation among laminin, glioblastoma electrotaxis,
and the perivascular invasion process may be important in glioblas-
toma cancer biology that requires further elucidation.
D. Electrotaxis behavior may reflect the heterogeneity
of glioblastoma
To further analyze how T98G and U-251MG cells migrate under
dcEF stimulation, the glioblastoma electrotaxis in serum-containing
(FBS) and serum-free media was examined.
1. T98G and U-251MG cells migrate toward opposite
directions under dcEF stimulation
Figures 3(a) and 3(b) display the directedness of T98G and U-
251MG electrotaxis. For the range of dcEF stimulations applied
(57.1–300V m1), T98G cells migrate toward the anode (positive elec-
trode) while the U-251MG cells migrate toward the cathode (negative
electrode), and the directedness increases with increasing dcEF.
Furthermore, the directedness in the electrotaxis of T98G cells is not
affected by the presence of fetal bovine serum (FBS) (P ¼ 0:45) but
the speed is significantly decreased (P < 0:0001) (Fig. S8). However,
the directedness of U-251MG cell electrotaxis is highly dependent on
the presence of FBS (P< 0.0001) and the speed of U-251MG electro-
taxis increases with FBS (P< 0.0001) (Fig. S8). The fetal bovine serum
is rich in growth factors, proteins, and ions, which can enhance the
chemical signaling in electrotaxis (Fig. S1). The electrotaxis and
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random migration of T98G and U-251MG with or without electrical
stimulation are shown in Videos S1–S4.
Both T98G cells and U-251MG cells are categorized as mesen-
chymal type glioblastoma;39,40 however, their electrotactic responses
are completely different. Similar results are reported in the electrotaxis
of other glioblastoma cells and spheroids15,16,19,41 as well as in lung
adenocarcinoma cells,31 showing that although cell lines can have sim-
ilar molecular and surface marker makeups, their electrotaxis
responses can be completely different. To better illustrate the direc-
tionality of T98G and U-251MG electrotaxis, directional migration
frequencies of T98G [Fig. 3(c)] and U-251MG [Fig. 3(d)] electrotaxis
are shown in rose plots.
FIG. 3. The electrotaxis and electro-alignment of T98G and U-251MG glioblastoma cells in HMEFC. (a) The electrotaxis directedness of T98G cells in four different electric
field strengths (EFSs); (b) the electrotaxis directedness of U-251MG cells in four different EFSs; [(c) and (d)] The rose plots showing the frequency of T98G (c) and U-251MG
(d) electrotaxis with and without electric field. The r-vectors displaying the direction tendencies of each group are indicated by arrows; P values in Mardia–Watson–Wheeler
tests are shown; (e) phase contrast images of T98G and (f) U-251MG cells before and after 6 h under 300 V m1 stimulation; the electric field is applied from left to right. Only
T98G cells demonstrate prominent perpendicular alignment under the electrical stimulation.
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Furthermore, the average size of T98G cells is larger than that of
U-251MG cells and the size of T98G cells also increases in the first 3 h
of electrotaxis (Fig. S4), reflecting rapid cell morphology changes dur-
ing the electrotaxis. It is also observed that an enlarged multinuclei
subpopulation exists in T98G cells and these multinuclei cells exhibit
weak senescence-associated b-galactosidase activity (Fig. S5). The mul-
tinuclei cells are also electrotactic (Video S1) and associated with drug
resistance.57,58 In contrast, U-251MG cells are less electrotactic and
not all U-251MG cells respond to the electric field (Video S3). The
very different electrotaxis responses of the two cell lines may reflect
the fundamental cell heterogeneity of glioblastoma which has been
speculated to contribute to the recurrence and therapeutic resistance
after anti-tumor therapy.59–64
Further elucidation of the correlation among electrotactic
responses, metastatic properties of glioblastoma, and in situ electric
field around the lesion may be beneficial to evaluate electrotaxis
response as a predictive tool for glioblastomametastasis.
2. Only T98G cells demonstrate prominent electro-
alignment behavior under electrical stimulation
Aside from directional migration in the dcEF, cells may also
demonstrate long axial alignment in perpendicular to the dcEF vector.
While this phenomenon is commonly observed among many cell
types,31,65–68 the molecular mechanism and the biological role are not
clear. Electro-alignment may participate in the cytoskeletal restructur-
ing in tissue morphogenesis,69,70 but biophysical studies show that
in vitro microtubules align in parallel to electric field vectors rather
than perpendicular.71,72
Figure S6 shows orientation of the cells with respect to time in
electrically stimulated T98G and U-251MG cells over 6 h. The orienta-
tion index is defined as the average cosine of two times the angle
between the long axis of a cell and the electric field vector (See more
details in Fig. S13 and Table S5). For a group of perpendicularly ori-
ented cells, the average orientation index is 1 and for a group of par-
allely orientated cells, the average orientation index is 1. For a group of
randomly arranged cells, the average orientation index should be 0.
Only T98G cells show prominent perpendicular alignment after elec-
trical stimulation (Indexorientation at 0 h vs 6 h is 0.11 vs 0.83,
P< 0.0001). FBS deprivation slightly decreases the alignment tendency
and delays the onset but does not abolish it (Indexorientation of serum
free vs 10% FBS at 6 h is 0.48 vs 0.83, P< 0.0001). However,
U-251MG does not show any perpendicular alignment. These results
further illustrate the heterogeneity of glioblastoma cells. The cell elec-
troalignment phenotypes of T98G and U-251MG after dcEF stimula-
tion are shown in Figs. 3(e) and 3(f).
E. Glioblastoma electrotaxis requires extracellular
calcium
Calcium ion flux is known to be involved in the electrotaxis sig-
naling of multiple cell types including mouse fibroblasts, human pros-
tate cancer cells, and neural crest cells.73–77 Deregulation of calcium
influx in the cells reduces actin polymerization and affects cell motility
speed but its effect on electrotactic directedness varies depending on
cell types.73,77 The hypothesis that glioblastoma electrotaxis is depen-
dent of extracellular calcium cations is tested in this work (Fig. S8).
First, a calcium-free, serum-free cell culture medium (CaFree SF)
is used to test if glioblastoma electrotaxis requires extracellular cal-
cium. T98G cells lose viability both with and without dcEF stimulation
[Figs. S8(a) and S11]. The lack of calcium ions in cell culture media
may impact calcium homeostasis significantly but the loss of viability
is rescued by the addition of 10% FBS, which contains calcium and
growth factors. The electrotaxis of U-251MG in calcium-free, serum-
free media is not affected compared to those in serum-free media
(P> 0.99). Interestingly, the electrotactic speed of U-251MG in
calcium-free serum-free media is greater (P< 0.0001).
Second, to validate that calcium cations are important, cation
chelators ethylenediaminetetraacetic acid (EDTA) and ethylene glycol-
bis(2-aminoethylether)-N,N,N0,N0-tetraacetic acid (EGTA) are used to
chelate the free calcium in the cell culture media with 10% FBS.
Treatment of 2mM EDTA significantly suppresses the directedness of
only U-251MG cells [P< 0.0001, Fig. S8(c)]. To further confirm that
the electrotaxis inhibition is due to extracellular calcium cations,
EGTA, a divalent cation chelator with increased affinity toward Ca2þ,
is used. At 1mM EGTA, the electrotactic directednesses of neither cell
lines is affected but their electrotactic speeds become more dispersed
(P< 0.0001). Under 2mM EGTA treatments, the electrotactic direct-
edness of U-251MG cells is reduced (P< 0.0001). When 5mM EGTA
is used, the electrotaxis of both cell lines is further repressed in both
directedness and speed and the cells detach from the substrate. These
results suggest that glioblastoma electrotaxis requires extracellular cal-
cium cations and calcium influx may be important for electrotaxis,
particularly that of U-251MG cells.
F. Glioblastoma electrotaxis is mediated by voltage-
gated ion channels
Ions channels expressed on glioblastoma cells including various
potassium, calcium, sodium, and chloride ion channels are believed to
facilitate pathogenesis of glioblastoma.27,78–80 Although the expres-
sions of numerous ion channels vary among clinical glioma samples,25
ion channel expression profiles have been suggested to predict survival
in glioma patients.81,82 Glioblastoma cells are immersed in the local
field potentials within the brain, and extracellular calcium is required
for glioblastoma electrotaxis which can flow into the cells through
voltage-gated calcium channels (VGCCs). Whether and how VGCCs
participate in the electrotaxis of glioblastoma may shed new insights
for inhibiting glioblastoma infiltration.
VGCCs are known to play important roles in glioma biology
such as cell proliferation, apoptosis, and sensitization to ionizing radia-
tion.27,83,84 VGCCs can be categorized as high voltage activated
(HVA) or low voltage activated (LVA) types.85–87 Among the HVA
VGCCs, four subtypes can be categorized by the electrophysiological
property and genetic phylogeny, including L-type (long-lasting, Cav
1.1–1.4), P/Q-type (purkinje/unknown, Cav 2.1), N-type (neural, Cav
2.2), and R-type (residual, Cav 2.3) VGCCs. The LVA VGCCs are
composed of T-type channels (transient, Cav 3.1–3.3). Although the
involvement of VGCCs in the electrotaxis of glioblastoma is not yet
elucidated, VGCCs’ role in electrotaxis of other cell types has been
proposed. Trollinger et al., found that a stretch-sensitive VGCC medi-
ates the electrotaxis of human keratinocytes.88 Aonuma et al., reported
that T-type VGCC mediates the electrotaxis of green paramecia.89 L-
type VGCCs also regulate the chondrogenesis during early limb devel-
opment which is known to be a bioelectricity process.90
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Another class of membrane proteins that are bioelectrically acti-
vated is voltage-gated potassium channels (VGKCs), which are repre-
sented by 12 families (Kv 1–Kv 12). VGKCs are involved in diverse
physiological and pathological processes regulating the repolarization
of neuromuscular action potential, calcium homeostasis, cellular pro-
liferation, migration, and cancer proliferation.91–97 Voltage-gated
potassium channel Kv 1.2
98 and non voltage-gated inwardly rectifying
potassium channel Kir 4.2
99 have been shown to be involved in the
sensing of electric field and signaling of cell electrotaxis. The potassium
ion transporters confer biophysical signals that are key for regulating
stem cells and tumor cell behavior in the microenvironment.100 In
prostate cancer cells, VGKC expressions are linked to the increased
metastatic potential.101 Furthermore, inhibition of Kv 1.3 VGKC has
been shown to induce apoptosis of glioblastoma cells in vitro.102
The role of VGCCs in glioblastoma cell electrotaxis is investi-
gated by using pharmacological inhibitors (Table S3). Many of these
inhibitors are short peptides purified or recombinant engineered from
venoms of poisonous species. When testing inhibition, cytochrome C
was added to the culture media to prevent non-specific adsorption of
peptide inhibitors to microfluidic chips.103 The detailed results of
pharmacological VGCC inhibition on the electrotaxis of T98G and U-
251MG cells are shown in Figs. 4(a), S9, S10, and Table S4. The work-
ing concentrations of pharmacological inhibitors do not impact cell
viability or random cell migration compared to control groups in 10%
FBS (Fig. S7 and Table S4).
In both glioblastoma cell lines, inhibition of L-type HVA VGCC
with gadolinium104 or nicardipine105 exhibits no effect on electrotactic
directedness (P> 0.99) nor on speed (P> 0.15) (Fig. S9). Inhibition of
N-type HVAVGCCs withx-Conotoxin GVIA106,107 also has no effect
on the electrotaxis of either cell type (P> 0.92).
1. T98G electrotaxis is mediated by R-type HVA VGCC
The electrotaxis of T98G is repressed when treated with cadmium
that is a broad spectrum HVA VGCC inhibitor at 50lM and 100lM
[P< 0.0001, Fig. 4(a)].108,109 Upon further identification, the directed-
ness in T98G electrotaxis is repressed by use of SNX482, an R-type
VGCC inhibitor110,111 (P¼ 0.049). The direction tendency is decreased
by the presence of SNX482 as presented by directional statistics
(P ¼ 0:002, Mardia–Watson–Wheeler test) [Fig. 4(b)]. The electro-
taxis of T98G cells repressed with SNX482 is shown in Video S5.
Calmodulin, a calcium binding protein, mediates many of the
Ca2þ dependent-signaling by interacting with VGCCs and maintaining
intracellular calcium homeostasis.112,113 However, the electrotaxis of
T98G is not dependent on calmodulin by inhibition with calmidazolium
[P> 0.99, Fig. 4(a)] and Ni2þ treatment has no inhibition on T98G cells
(P> 0.99), which has partial inhibition on R-type VGCC.111,114 These
results imply that an alternative mechanismmight be at play.
2. U-251MG electrotaxis is mediated by P/Q-type HVA
VGCCs
U-251MG electrotaxis has exhibited its dependency on HVA
VGCCs. Decreased directedness and speed are observed in U-251MG
cells treated with 100lM cadmium (P¼ 0.0372, Table S4). Upon fur-
ther identification, U-251MG electrotaxis directedness is repressed
when treated with P/Q-type HVA VGCC inhibitor using agatoxin
IVA and conotoxin MVIIC (P< 0.0001) [Fig. 4(a)]. However, the
electrotactic speed is not affected by agatoxin IVA (P> 0.99) but
decreased by conotoxin MVIIC (P< 0.0001) (Fig. S10). The electro-
tactic directedness of U-251MG is dependent on calmodulin
(P< 0.0001). The electrotaxis of U-251MG is repressed by the treat-
ment of agatoxin IVA, shown in Video S6. The direction tendency of
U-251MG electrotaxis is decreased by the presence of x-conotoxin
MVIIC as presented by directional statistics (P< 1E-12,
Mardia–Watson–Wheeler test) [Fig. 4(d)].
Furthermore, the electrotactic directedness of U-251MG cells is
suppressedd with nickel (P< 0.0001) and amiloride (P< 0.01) as well
as the electrotactic speed (P< 0.0001) [Figs. 4(a) and S10]. These results
suggest a possible involvement of T-type VGCC115 in U-251MG elec-
trotaxis. However, U-251MG electrotaxis is not affected when tested
using another potent T-type VGCC inhibitor, TTA-A2.116,117
3. T98G electrotaxis and U-251MG electrotaxis are also
mediated by A-type VGKCs and acid-sensing sodium
channels
In T98G electrotaxis, cadmium and SNX482 inhibit the R-type
HVAVGCC and decrease the electrotaxis directedness. However, cad-
mium and SNX482 have also been reported to block rapid inactivating
(A-type) transient outward VGKC (Kv 4.3) so experimental results of
SNX482 should be interpreted carefully.118–120 Using 5lM AmmTx3,
a member of the a-KTX15 family of scorpion toxins, to block A-type
VGKCs (Kv 4.2 and Kv 4.3),
121–123 T98G electrotaxis directedness
(FBS vs AmmTx3 of –0.69 vs –0.39, P¼ 0.0025) and speed (FBS vs
AmmTx3 of 9.99 vs 4.42, P < 0:0001) are repressed but not
completely abolished (Table S4). Furthermore, the inhibition of T98G
directeness caused by SNX482 is stronger than those by AmmTx3
(SNX482 vs AmmTx3 of –0.27 vs –0.39, P¼ 0.039, two-tailed t test).
Another broad spectrum transient VGKC inhibitor, 4-aminopyridine
(4-AP), is used to confirm the results from AmmTx3.124–126 Under
1mM 4-AP, the directedness and speed in T98G electrotaxis are both
repressed (P< 0.0001, Fig. 4). Increasing the concentration of 4-AP to
4mM, even though electrotactic directedness has not changed
(P> 0.99) compared to the control case, the migration speed is
decreased (P< 0.0001). This is likely an artifact caused by part of
T98G cells detaching from the surface rather than from the effect of
actual electrotaxis (Fig. S11). These results suggest that T98G electro-
taxis may be mediated by A-type VGKCs (Kv 4.3), but the involve-
ment of R-type VGCCs cannot be completely ruled out. A-type
VGKC is also known to regulate calcium flux and resting membrane
potential in astrocytes127,128 and therefore may interact with calcium
channels during glioblastoma electrotaxis. The directional tendency of
T98G electrotaxis is decreased by inhibiting A-type VGKC as pre-
sented by directional statistics (P< 1E-12, Mardia–Watson–Wheeler
test) [Fig. 4(c)].
Similar inhibition of A-type VGKC also represses U-251MG
electrotaxis. When U-251MG cells are treated with AmmTx3 and
4-AP, the electrotaxis directedness is inhibited by both compounds
(P< 0.0001) and the speed is repressed in only 4-AP (P< 0.0001)
but not AmmTx3 (P¼ 0.09) (Fig. S10). The directional tendency
of U-251MG electrotaxis is also decreased by inhibiting A-type
VGKC as presented by directional statistics (P< 1E-12,
Mardia–Watson–Wheeler test) [Fig. 4(e)]. The electrotaxis of
T98G and U-251MG is suppressed when A-type VGKC is
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inhibited through 1mM 4-AP (more details shown in Videos S7
and S8). Further molecular studies to explore the roles of VGCCs
and VGKCs in glioblastoma electrotaxis are important for future
studies.
Furthermore, nickel and amiloride repress the directedness of
U-251MG electrotaxis but not through T-type VGCC. At a high con-
centration of nickel and amiloride, the compounds may inhibit the
acid-sensing ion channel (ASIC) and epithelial sodium channel (ENaC),
which are members of a superfamily of voltage-insensitive mechanosen-
sitive sodium channels.129,130 Furthermore, ASIC sodium channels are
specifically expressed in the high-grade glioma cells but not in normal
brain tissues or low grade glial cells.131,132 Sodium ion flux is known to
mediate electrotaxis in keratinocytes through ENaC sodium channels133
and prostate cancer cells through voltage-gated sodium channels.134–136
FIG. 4. Inhibitory effects of selected ion
channels on glioblastoma cell electrotaxis.
(a) The electrotactic directedness of T98G
and U-251MG glioblastoma cells under
300 V m1 dcEF after 6 h with pharmacolog-
ical inhibition on various ion channels. † indi-
cates the electrotaxis tested against those
without EF stimulation; ‡ indicates the elec-
trotaxis group tested against those with cyto-
chrome C which prevents adsorption of
short peptides to experimental apparatus; All
other groups are statistically compared to
their respective controls in cell culture media
with 10% FBS; n.s. indicates not significant;
 indicates P< 0.05;  indicates P< 0.01;
 indicates P< 0.001;  indicates
P< 0.0001; the numbers in parentheses
indicate actual P-values; [(b) and (c)] Rose
plots showing the frequency of T98G electro-
taxis with and without the presence of
SNX482 (R-type VGCC inhibitor) and 4-AP
(A-type VGKC inhibitor); the r-vectors dis-
playing the direction tendencies of each
group are indicated by the arrows; P values
in Mardia–Watson–Wheeler tests are shown;
(d) and (e) rose plots showing the frequency
of U-251MG electrotaxis with and without
the presence of x-conotoxin-MVIIC (P/Q-
type VGCC inhibitor) and 4-AP; The r-
vectors displaying the direction tendencies of
each group are indicated by the arrows; P
values in Mardia–Watson–Wheeler tests are
indicated. Note that the scale in [(b) and (d)]
is different from that in [(c) and (e)] due to
different numbers of cells analyzed. The his-
tograms represent the frequencies of cells
moved in each direction.
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To confirm the involvement of ASIC sodium channels in U-
251MG electrotaxis, U-251MG cells are treated with 5lM benzamil
hydrochloride (Alomone labs, USA).137–139 The directedness of U-
251MG electrotaxis is significantly repressed by benzamil treatment
[FBS vs benzamil¼ 0.58 vs 0.29, P< 0.0001, Fig. 4(a)] but not the
speed (P¼ 0.42) (more details in Fig. S10). Benzamil is also tested on
T98G electrotaxis and found to inhibit its directedness (P< 0.01) and
speed (P< 0.0001).
4. Various ion channels participate in the electrotaxis of
glioblastoma cells of different origins
The pharmacological studies on the ion channels in T98G and
U-251MG electrotaxis suggest that multiple ion channels, which may
be voltage-sensitive or not, can mediate the sensing of endogenous
electric field and initiate the migratory response.13 The proposed
mechanism is highlighted in Fig. 5.
A-type VGKC, R-type VGCC, and ASIC sodium channels medi-
ate the electrotaxis of T98G cells while P/Q-type VGCCs, A-type
VGKC, and ASIC sodium channels mediate the electrotaxis of U-
251MG cells. These results suggest that ion channel expression profiles
are cell line specific and correlating ion channel expressions with elec-
trotactic phenotypes of cancer cells may be beneficial to provide new
insights of metastasis-aimed therapeutics by inhibiting electro-
taxis.140,141 If glioblastoma infiltration can be inhibited by targeted
therapeutics, the quality-of-life and prognosis of glioblastoma patients
could be improved. The downstream molecular signaling of VGCCs,
VGKCs, and ASIC sodium channels in glioblastoma electrotaxis is an
interesting future direction to investigate. Recently, glutamatergic
receptors have also been shown to mediate neuron-glioma interaction
and glioma progression through calcium signaling.142–144 Therefore, a
systematic screening of potassium channel, sodium channel, and glu-
tamate receptor ion channels’ ability to mediate glioblastoma electro-
taxis is necessary to map the signaling network that may contribute to
glioblastomametastasis.
Our results together with previous reports15,16,19,41 suggest that
electrotaxis may be an ensemble phenotype contributed by many sig-
naling pathways, including chemical signaling, mechanosensing, and
electrical activation (Fig. S1). The electrotaxis behavior may be highly
dependent on the gene expression, membrane receptor composition,19
and assembly of signaling complexes in lipid rafts.145 Therefore, phe-
notypic characterization of cell electrotaxis and identification of mem-
brane receptor compositions may help identify important molecular
targets in a personalized medicine approach given that induced migra-
tion by physiological electric field may contribute to intracranial
metastasis. The multiplex hybrid microdevices and machine learning-
assisted quantitative analysis developed in this work can be very useful
for systematic phenotype profiling and identification of molecular
mechanisms underlying cell electrotaxis.
III. CONCLUSION
As proof of principle, the hybrid PMMA/PDMS microfluidic
chip demonstrates robustness and versatility for multiplex electrotaxis
studies. Cell migration in multiple dcEFs under multiplex conditions
can be studied in a single experiment in combination with automated
microscopy. The submerged operation balancing the inlet/outlet
hydrostatic pressures guarantees a stable microenvironment that
avoids microbubbles, ensures uniform cell seeding, and minimizes
required number of cells. Uniformly distributed single cells can be reli-
ably seeded in a microfluidic chip that further increases the robustness
and reproducibility of multiplex experiments. Use of machine
learning-enabled single cell migration analysis automates the cell
migration data analysis workflow for reliable quantitative data at high
throughput, opening new opportunities for quantitatively studying cell
responses in well-controlled microenvironments.
GeltrexTM coating has been identified to support a reproducible
electrotaxis model of T98G and U-251MG glioblastoma cells. The het-
erogeneity responses of T98G and U-251MG electrotaxis and the
importance of calcium signaling are identified. By further inhibitorial
study, the electrotaxis of T98G may depend on R-type HVA VGCCs,
A-type VGKCs, and ASIC sodium channels. The electrotaxis of U-
251MG depends on P/Q-type HVA VGCCs, A-type VGKCS, and
ASIC sodium channels. Multiple ion channels, which may be voltage-
sensitive or not, can mediate the sensing of electric field and electro-
taxis in different glioblastoma models, suggesting that glioblastoma
infiltration can be amplified by endogenous electric field in a tumor
sample-dependent manner. The roles of ion channels in gliomametas-
tasis and survival with regard to physiological electric field require fur-
ther systematic studies and in vivo validation.
IV. METHODS
A. Hybrid multiple electric field device (HMEFC)
design, simulation, and fabrication
Using the hybrid PMMA/PDMS approach, the prototyping dis-
advantages in both materials can be mitigated while the advantages
can be combined. In PMMA, complex 3D structures for fluidic routing
or reservoir and world-to-chip interface can be quickly prototyped by
CO2 laser cutting and thermal bonding. However, spatial resolution
using this approach is not sufficiently high to create reliable microflui-
dic environments. In contrast, precise quasi-two dimensional micro-
structures can be fabricated using the soft lithography technique in
PDMS microfluidic chips. But standard soft lithography for PDMS
FIG. 5. The signaling mechanism identified in this study. Laminin-based ECMs is
necessary for glioblastoma electrotaxis, suggesting that integrins may play a role.
The voltage-gated ion channels and ion transporters also mediate glioblastoma
electrotaxis that requires extracellular calcium.
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fluidics is limited in the 3D design and world-to-chip interface. By
using a dual-energy double-sided tape, PMMA and PDMS substrates
can be easily and reversibly bonded,17,146 enabling broad experimental
flexibility.
In HMEFC, two PMMA components for a world-to-chip inter-
face and electrical application were adhered to a PDMS chip that con-
tained a double-layer microchannel network where cells were cultured
in and observed [Fig. 1(b)]. By double-layer microchannel design [Fig.
1(c)], experiments with two different cell types or chemical treatments
with four electric field strength (EFS) conditions could be performed
in a single chip.
To create multiple dcEFs, the HMEFC was designed by a R-2R
resistor ladder configuration17,31,32 to create theoretical 5.25:2.5:1:0-
ratio multiple EFs in Secs. I–IV and V–VIII [Fig. 1(c)]. The cells
exposed to the highest dcEF were closest to the outlets to avoid para-
crine signaling from electrically stimulated cells to un-stimulated cells.
By using the double-layer design, the hydraulic resistances in the
10lm-high, 0.84mm-wide interconnecting channels were much
higher than the two 100lm-high, 2mm-wide main channels where
cells resided, limiting the advectional chemical transport and avoiding
“cross-contamination” events that further increased the high experi-
mental throughput (see detailed discussion on chip design in the sup-
plementary material).
Coupled numerical simulation of electric field, creeping flow, and
chemical transport was carried out by finite element methods
(COMSOL Multiphysics 5.3, COMSOL, USA). To correctly simulate
the system, in-house measured material properties of the minimum
essential media a (MEMa) supplemented with 10% FBS medium were
measured and input in COMSOL. The liquid material properties of
the 3D model were set as water with a density of 1002.9Kg m3, an
electrical conductivity of 1.536 S m1, a dynamic viscosity of 0.946
mPa s, and a relative permittivity of 80. The numerically simulated
electric field ratio was 4.99: 2.45:1:0 in Secs. I–IV and V–VIII with lim-
ited chemical transport across the interconnecting channels as
designed (Fig. S15).
To fabricate a HMEFC, first, the PDMS chip was fabricated by a
soft lithography technique.147 The double-layer microfluidic design
was fabricated into a mold using negative photoresists (10lm and
100lm) on a silicon wafer using direct-write lithographic writer and
mask aligner (DL-1000, Nano Systems Solution, Japan and MA/BA6,
SUSS MicroTec, Germany). After passivation of the mold with per-
fluorosilane, mixed PDMS monomer (10:1 monomer:curing agent
ratio, Sylgard 184, Corning, USA) was poured and cured on the master
mold in a custom-made casting block, which ensures the 4mm thick-
ness in finished PDMS devices. After degassing, a piece of 15mm-
thick PMMA block was placed on top of the casting block to ensure
the surface flatness of PDMS. The PDMS was cured in an oven and
cut to yield individual devices. 1mm-wide inlets and outlets were
punched on cured PDMS devices and the PDMS devices were bonded
to cover glasses (0.17mm-thick) using O2 plasma, completing the
PDMS chip.
Second, the PMMA components were fabricated by cutting the
four-layer design on a 2-mm thick cast PMMA substrate (Kanase,
Japan) using a CO2 laser cutter (VLS3.50, Universal Laser Systems,
USA). The layers were aligned and thermally bonded on a program-
mable automated hot press with temperature and pressure control (G-
12RS2000, Orihara Industrial Co., ltd, Japan). Third, dual energy
double-sided tape (No.5302A, Nitto, Japan) was patterned using the
CO2 laser cutter and used to join the PMMA components and the
PDMS chip.17,146 A PMMA top reservoir for submerged cell seeding
was also fabricated by four layers of 2mm-thick PMMA pieces using
laser cutting and thermal bonding. The PMMA top reservoir was
affixed on top of the two PMMA components through PDMS padding
frames with dual energy double sided tapes, completing the assembly
of HMEFC for cell seeding.
The detailed description for the HMEFC design, simulation, and
fabrication can be found in the supplementary material.
B. Cell culture and maintenance
Glioblastoma cell lines T98G (CRL-1690, ATCC, USA) and U-
251MG (IFO50288, JCRB, Japan) were obtained from the respective
tissue banks and thawed according to the received instructions. Ethics
approval is not required. T98G and U-251MG were cultured in mini-
mum essential media a (MEMa) supplemented with 10% FBS and
2.2 g L1 under 37 C, 5% CO2 moist atmosphere (MCO-18AIC,
Sanyo, Japan). The cells were subcultured every other day or whenever
cells reached 80% confluency. Mycoplasma contamination was
checked every three months using a mycoplasma species-specific PCR
kit (e-Myco plus, iNtRON, Korea) on a thermocycler (C1000, Bio-
Rad, USA).
Frozen stocks of the cells were prepared by resuspending 1 106
log-phase cells in 1ml CellBanker solution (Takara Bio, Japan) and
cooled down in a freezing container (Mr. Frosty, Nunc, USA) in
80 C overnight. The frozen cells were then transferred into the gas-
eous phase of liquid nitrogen for long term storage (Locator 6,
Thermo Scientific, USA).
C. Cell viability testing and senescence staining
The viability of cells under various media conditions and differ-
ent chemical concentrations was tested using alamarBlue reduction
assay (BUF012B, Bio-Rad, USA). The T98G and U-251MG cells were
seeded in 96-well microplate wells at the number of 5 103 log-phase
cells per well. Each experimental condition was performed in triplicate
where cells were incubated with different chemicals at working con-
centrations (Table S3) for 12 h before alamarBlue was further added
and incubated for 4 h at 37 C. Optical absorbances at 570 and 600nm
were measured on a microplate reader (Multiskan GO, ThermoFisher
Scientific, USA). The viability was calculated based on the manufac-
turer’s instructions and compared to that of the control set of cells in
the media containing 10% FBS.
T98G cells have large and multinuclei subpopulations which
have been proposed to play a role of drug resistance.57,58 The
senescence-associated b-galactosidase activity in T98G cells was inves-
tigated following manufacturer’s instructions (9860, Cell Signaling
Technology, USA). T98G cells conditioned with 50lM hydrogen per-
oxide for 3 h and subcultured for 2 days were used as a positive
control.148
D. Cell seeding and electrotaxis experiment
The cell experiment workflow included salt bridge preparation,
priming of microchannels, coating substrate with ECM, seeding cells,
assembly of world-to-chip interface, and electrotaxis experiment.
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First, sterilized 1% molten agarose (Seakem LE agarose, Lonza,
USA) dissolved in 1X phosphate buffered saline (PBS) was injected on
the salt bridge junctions of the PMMA component B and allowed to
gel [Fig. 1(b)]. The salt bridge served as a solid electroconductive sepa-
ration in electrotaxis experiments between the cell culture media and
electrode, avoiding formation of complex electrolysis products.
Second, 50ll 99.5% ethanol (Wako, Japan) loaded in 200ll
pipet tips were used to wet the microchannels in the PDMS chip by
capillary flow and gravity flow.17,149 The microchannels were then
washed with ultrapure water. The inlet/outlet ports were submerged
under liquid solutions in all steps afterward to ensure bubble-free
microchannels.
Third, 150ll of appropriate ECM solutions such as GeltrexTM
was loaded in tips and inserted on one side of inlet/outlet ports. The
ECM solutions were allowed to flow into chip passively and incubated
for 1 h at 37 C. After ECM coatings, the channels were washed once
with PBS and MEMa. The top reservoir was then filled with MEMa
until the inlets and outlets were under the same liquid level, balancing
the inlet/outlet hydrostatic pressure.
Log-phase glioblastoma cells were washed with 1X PBS, trypsi-
nized (TrypLE, Thermo Fisher Scientific, USA), counted on a bench-
top flow cytometer (Muse counting and viability kit, Millipore, USA),
centrifuged at 300g for 5min, and resuspended in MEMa media
with 10% FBS at 106 cells ml1. An appropriate amount of cell suspen-
sion was injected into the microchannels using a 200ll micropipet.
Due to the small volume in microchannels, only a minute amount of
cell suspension was needed. The cells were allowed to adhere in the
chip under a 37 C, 5% CO2 moist atmosphere for 3–5h.
After cell seeding and adhesion, the top reservoir was removed
for optical clarity. A piece of 4mm-thick PDMS slab punched with
two outlet holes (21G, Accu-punch MP, Syneo Corp, USA) was
affixed to the top of component B through the first piece of patterned
double-sided tape [Fig. S17(a)], creating an air-tight seal.
To start the electrotaxis experiment, fresh media were supplied
in the reservoirs on component A of HMEFC. Two sets of tubings
(06419–01, Cole Parmer, USA) with stainless tubes (21RW, New
England Small Tubes, USA) on one ends and double Luer gel dis-
pensing needles on the opposite ends (23G, Musashi, Japan) were
used. The tubings were sterilized before priming with 1X PBS with
2.5ml syringes (Terumo, Japan). The stainless tube ends were
inserted into the 21G holes of the PDMS slab on the HMEFC. The
syringes were mounted on a syringe pump (YSP-202, YMC, Japan)
and set in withdrawal mode to perfuse the cells on HMEFC. The
HMEFC was completed and ready for the electrotaxis experiment
[Fig. 1(b)].
Two HMEFCs were prepared in one experiment that allowed 16
conditions to be screened simultaneously. HMEFCs were affixed in a
microscope on-stage incubator (WKSM, Tokai-hit, Japan). A feedback
thin-film K-type thermocouple was attached to the glass bottom of a
HMEFC (60lm-thick, Anbesmt, Japan) and regulate the incubator to
maintain the environmental temperature at 37 C.
A U-shaped PMMA salt bridge filled with 1% molten agarose in
PBS was used to connect the two HMEFCs electrically by inserting
into the ajoining PBS reservoirs on each HMEFC’s component B.
300V m1 dcEFs were established in Secs. I and V [Fig. 1(c)] through
two home-made silver/silver chloride (Ag/AgCl) wire electrodes31,49
inserted in the PBS reservoirs on component B by a source measure
unit (SMU 2410, Keithley, USA). Time lapse phase contrast images of
each condition were taken on an automated phase contrast micro-
scope (Ti-E, Nikon, Japan). The setup is shown in Fig. S12.
For electrotaxis of glioblastoma on different ECM coatings, dif-
ferent ECM coatings were coated in the microchannels and electro-
taxis experiments were performed in MEMa with 10% FBS for 6 h.
To test if the electrotaxis of gliblastoma cells require extracellular
Ca2þ, calcium-free Dulbecco’s minimum essential medium (CaFree
DMEM, 21068, Gibco, USA) or cation chelators such as ethylenedia-
minetetraacetic acid (EDTA) (15575, Thermo Fisher Scientific, USA)
and ethylene glycol-bis(2-aminoethylether)-N,N,N0,N0-tetraacetic acid
(EGTA) (08907–84, Nacalai, Japan) were used (Table S3). Before dcEF
stimulation, cells were incubated in CaFree DMEM or MEMa with
10% FBS mixed with calcium chelators at indicated molar concentra-
tions for 2 h at 20ll h1. Afterward a direct electric current was
applied through Ag/AgCl wire electrodes in D-PBS buffer on the
PMMA component B by the source measure unit and cell behaviors
were observed for six hours.
To investigate if voltage-gated ion channels mediate the electro-
taxis of glioblastoma cells, the inhibitors were added to fresh MEMa
media with 10% FBS at appropriate working concentrations (Table
S3). The reagents were supplied in the reservoirs on the PMMA com-
ponent A of HMEFCs after cells were seeded. The inhibitor-
containing media were infused into the channels at 20ll min1 for
10min before changing to 20ll h1 and incubated for 30min. A
direct electric current was applied through Ag/AgCl wire electrodes in
PBS buffer on the PMMA component B by the source measure unit
and cell behaviors were observed for six hours.
E. Microscopy imaging and data processing
A Nikon Ti-E automated microscope with a Perfect Focus
System and motorized XYZ stage was used to perform all microscopy
experiments. A 10 phase contrast objective and intermediate magni-
fication of 1.5 were used for taking 10-min interval phase contrast
images with a scientific CMOS (sCMOS) camera with 2 2 binning
(Orca Flash 4.0, Hamamatsu, Japan) in NIS Element AR software
(Nikon, Japan). The spatial resolution at this setting was  0.87lm
pixel–1. All experiments were performed in triplicate.
After each experiment, images were exported from NIS element
software as tiff files and automatically organized by XY positions into
folders using an in-house developed Python script. The cells in the raw
images were segmented, tracked, and automatically analyzed using the
Usiigaci software.30 Only cells tracked throughout all the frames in one
viewfield were analyzed. At least 100 cells in every conditions were
analyzed for cell-centric features such as the directedness, speed, and
orientation changes before and after electric field or chemical stimula-
tion (Table S5).
Briefly, the definitions of key cell-centric features used to quantify
cell electrotaxis (Fig. S13) were listed below:
• Area The cell area was extracted as the average area (lm2) which




N , where Ai was
the area of each cell, and N was the total number of analyzed
cells.
• Directedness
The directedness of cell electrotaxis was defined as the average




N , where Ui
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was the angle between the Euclidean vector of each cell migration
and the vector of applied EF (from anode to cathode), and N was
the total number of analyzed cells. A group of anodal moving
cells held a directedness of 1; and a group of cathodal moving
cells held a directedness of þ1. For a group of randomly migrat-
ing cells, the directedness was zero.
• Speed
The speed of cell electrotaxis was defined as the average of cell








where the dnet was the Euclidean distance traveled by each cell,
and telapsed was the time elapsed, and N was the total number of
analyzed cells.
• Orientation
The orientation was defined as the average cosine of two times





where hi was the angle between the applied EF vector and the
long axis of a given cell; N is the total number of cells analyzed. A
group of cells aligned perpendicular to the EF held an orientation
of 1; and a group of cells aligned in parallel to the applied EF
held an orientation of þ1. For a group of randomly shaped cells,
the average orientation was zero.
The cell-centric features were computed automatically and saved
as Excel spreadsheets (Office365, Microsoft, USA) as part of the
Usiigaci software analysis pipeline. The data were further statistically
inferenced by inputting the data in statistical software (Prism 7,
GraphPad LLC, USA). All data were presented as the mean6 95%
confidence interval, which was 1.96 of standard error of mean, from
triplicate experiments. Two-tailed Student’s t tests or one-way analyses
of variance (ANOVA) with Tukey’s multiple-comparison post-hoc
tests were performed for statistical testing between two groups or mul-
tiple groups. The results from one-way ANOVA were reported until
noted otherwise. The confidence level to reject a null hypothesis
between two datasets was set at 95%. A p-value (P, the probability for
a true null hypothesis) less than 0.05 represented a statistical signifi-
cance at 95% confidence.
The directional tendencies of glioblastoma electrotaxis were also
analyzed in directional statistics (Oriana 4, USA). The X-Y displace-
ments of glioblastoma cell electrotaxis after 6 h were calculated into
angles by trigonometry and plotted in angle histogram plots (rose
plots). A non-parametric Mardia–Watson–Wheeler test was per-
formed to test if the migration tendencies of two groups were identi-
cal.150 The P value less than 0.05 represented confidence to reject null
hypothesis at 95% confidence level.
SUPPLEMENTARY MATERIAL
See the supplementary material for the supplementary figures,
supplementary tables, supplementary videos, and detailed description
of HMEFC chip design, simulation, and fabrication.
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